hedamycin has been researched along with nogalamycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beerman, TA; Rauscher, FJ; Welch, JJ | 1 |
| Beerman, TA; Chiang, SY; Rauscher, FJ; Welch, JJ | 1 |
2 other study(ies) available for hedamycin and nogalamycin
| Article | Year |
|---|---|
Targeting DNA-binding drugs to sequence-specific transcription factor.DNA complexes. Differential effects of intercalating and minor groove binding drugs.
Topics: Anthraquinones; Base Sequence; Chromomycins; DNA; DNA-Binding Proteins; Echinomycin; Intercalating Agents; Leucine Zippers; Molecular Sequence Data; Nogalamycin; Oligodeoxyribonucleotides; Transcription Factors; WT1 Proteins; Zinc Fingers | 1994 |
Effect of DNA-binding drugs on early growth response factor-1 and TATA box-binding protein complex formation with the herpes simplex virus latency promoter.
Topics: Alkylating Agents; Anthraquinones; Base Composition; Chromomycin A3; Deoxyribonucleoproteins; Distamycins; DNA-Binding Proteins; Early Growth Response Protein 1; Gene Expression Regulation, Viral; Humans; Immediate-Early Proteins; Intercalating Agents; Macromolecular Substances; Nogalamycin; Promoter Regions, Genetic; Recombinant Fusion Proteins; Simplexvirus; TATA-Box Binding Protein; Transcription Factor TFIIA; Transcription Factors; Virus Latency | 1996 |